Serum BDNF Levels in Relation to Illness Severity, Suicide Attempts, and Central Serotonin Activity in Patients with Major Depressive Disorder: A Pilot Study

被引:27
|
作者
Park, Young-Min [1 ]
Lee, Bun-Hee [2 ]
Um, Tae Hyun [3 ]
Kim, Sollip [3 ]
机构
[1] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Psychiat, Goyang, South Korea
[2] Eulji Univ, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea
[3] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Lab Med, Goyang, South Korea
来源
PLOS ONE | 2014年 / 9卷 / 03期
基金
新加坡国家研究基金会;
关键词
AUDITORY-EVOKED-POTENTIALS; LOUDNESS DEPENDENCE; INTENSITY DEPENDENCE; NEUROTROPHIC FACTOR; ERP COMPONENTS; NORADRENERGIC ANTIDEPRESSANTS; TREATMENT RESPONSE; CLINICAL-RESPONSE; BIPOLAR DISORDER; N1/P2; COMPONENT;
D O I
10.1371/journal.pone.0091061
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this study was to test the hypothesis that serum levels of brain-derived neurotrophic factor (BDNF) are correlated with the loudness dependence of auditory evoked potentials (LDAEP). The question of whether there is a difference in BDNF levels between depressive patients according to their illness severity, history of suicide attempts, and central serotonin activity was also addressed. A sample of 51 patients who met the criteria for major depressive disorder following diagnosis using axis I of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders - text revision comprised the study subjects. The patients were stratified into two subgroups based on their illness severity, history of suicide attempts, and their LDAEP values. The LDAEP was evaluated by measuring the auditory event-related potentials, and serum BDNF was measured using blood sampling before beginning medication with serotonergic agents. There was no difference in serum BDNF levels between the two patient subgroups. The subgroup with moderate-to-severe depression (n = 16) was reanalyzed after stratifying it into two subgroups according to LDAEP and BDNF values (dichotomized at the medians into low and high). The high-LDAEP subgroup had higher serum BDNF levels and total Barratt Impulsiveness Scale score than the low-LDAEP subgroup (p = 0.03 and 0.036, respectively). Serum BDNF levels were positively correlated with LDAEP and total Beck Hopelessness Scale (BHS) score (r = 0.56, p = 0.025, and r = 0.59, p = 0.016, respectively). The high-BDNF subgroup had a higher LDAEP and total BHS score than the low-BDNF subgroup (p = 0.046 and p = 0.011, respectively). This is the first study to demonstrate a relationship between the BDNF level and LDAEP in Asian depressive patients. Intriguingly, the high-BDNF subgroup (divided according to illness severity) exhibited a more severe psychopathology on some psychometric rating scales, a finding that conflicts with previous results.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder
    Lin, Chin-Chuen
    Tsai, Meng-Chang
    Lee, Chien-Te
    Sun, Ming-Hsiang
    Huang, Tiao-Lai
    PSYCHIATRY RESEARCH, 2018, 270 : 232 - 237
  • [32] Association between increased serum interleukin-6 levels and sustained attention deficits in patients with major depressive disorder
    Ye, Gang
    Yin, Guang Zhong
    Tang, Zhen
    Fu, Jia Lin
    Chen, Jie
    Chen, Shan Shan
    Li, Jia
    Fu, Tian
    Yu, Xin
    Xu, Dong Wu
    Yao, Jeffrey K.
    Hui, Li
    PSYCHOLOGICAL MEDICINE, 2018, 48 (15) : 2508 - 2514
  • [33] The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study
    Tadic, Andre
    Wagner, Stefanie
    Schlicht, Konrad Friedrich
    Peetz, Dirk
    Borysenko, Liudmyla
    Dreimueller, Nadine
    Hiemke, Christoph
    Lieb, Klaus
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) : 415 - 420
  • [34] Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case-control study
    Salsabil, Lubaba
    Shahriar, Mohammad
    Islam, Sardar Mohammad Ashraful
    Bhuiyan, Mohiuddin Ahmed
    Qusar, M. M. A. Shalahuddin
    Islam, Md. Rabiul
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (04)
  • [35] Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
    Papakostas, G. I.
    Shelton, R. C.
    Kinrys, G.
    Henry, M. E.
    Bakow, B. R.
    Lipkin, S. H.
    Pi, B.
    Thurmond, L.
    Bilello, J. A.
    MOLECULAR PSYCHIATRY, 2013, 18 (03) : 332 - 339
  • [36] Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts
    Sowa-Kucma, Magdalena
    Styczen, Krzysztof
    Siwek, Marcin
    Misztak, Paulina
    Nowak, Rafal J.
    Dudek, Dominika
    Rybakowski, Janusz K.
    Nowak, Gabriel
    Maes, Michael
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 81 : 372 - 383
  • [37] Serum copper and zinc levels correlate with biochemical metabolite ratios in the prefrontal cortex and lentiform nucleus of patients with major depressive disorder
    Liu, Xuanjun
    Zhong, Shuming
    Li, Zhinan
    Chen, Junhao
    Wang, Ying
    Lai, Shunkai
    Miao, Haofei
    Jia, Yanbin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 99
  • [38] Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder
    Zhang Jun
    Yue Yingying
    Ashok, Thapa
    Fang Jianzhong
    Zhao Shengjun
    Shi Weihua
    Yang Zhong
    Li Yanfang
    Yuan Yonggui
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 250 : 432 - 438
  • [39] Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder
    Tseng, Ping-Tao
    Lee, Yu
    Lin, Pao-Yen
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 334 - 339
  • [40] Genome-wide copy number variation-, validation- and screening study implicates a new copy number polymorphism associated with suicide attempts in major depressive disorder
    Rao, Shitao
    Shi, Mai
    Han, Xinyu
    Lam, Marco Ho Bun
    Chien, Wai Tong
    Zhou, Keying
    Liu, Guangming
    Wing, Yun Kwok
    So, Hon-Cheong
    Waye, Mary Miu Yee
    GENE, 2020, 755